Bank Syariah Indonesia BRIS IJ - Buy - 2Q24 - Solid results with low CoC

Banks NS EW 615 4th Sep, 2024


BRIS continued to deliver solid 2Q24 bottom line performance with the numbers coming in largely in-line with our projections. The bank reported net profit of IDR1.7tn (-1% q-q; +24% y-y), bringing 1H24 profits to IDR3.4tn (+20% y-y), representing 54% of our FY24F projection. At the operating level, the bank reported 1H24 net financing income of IDR8.8tn (+3% y-y) and PPOP of IDR5.6tn (+4% y-y), a relatively soft result likely attributable to lack of asset yields’ repricing (was at 6.6% or -13bp y-y), while funding expenses increased (rising to 2.5% or +24bp y-y). The lack of repricing for financing (i.e. loans for conventional banks) has been a common trait across most Indonesia banks under our coverage. We attribute these to financing (or lending) competitions as well as tight liquidity. This translates to NFM (or NIM) of 5.3% (-54bp y-y) in 1H24. Having said that, we think in 4Q24F funding costs could improve, driven by potential cuts in BI rates as well as net reduction in SRBIs (giving room for liquidity improvement for the system). Among the major banks, we think BRIS has proportionally more fixed-yielding earnings assets than most conventional banks. We estimate ~55-60pct of total financings are fixed-yielding in nature. Further out, we expect BRIS to continue delivering higher financing growth than the sector average and stabilizing funding costs, which would reduce pressure on its NFM. These will be key earnings drivers in the medium term for the bank. Meanwhile, we expect asset quality to improve further, which could potentially lower provisions expense (CoC), as we have seen in its 2Q24 results. Hence, we reiterate our Buy rating on the stock with a TP of IDR3,100.

2Q24 result summary:

• 2Q24 Net financing/margin income (NFI) stood at IDR4.4tn (flat q-q and +4% y-y), bringing 1H24 NFI to IDR8.8tn (+3% y-y), accounting for 47% of our FY24F projections. The y-y growth primarily came from: 1) higher 2Q24 margin income of IDR 6.3tn (+0% q-q; +11% y-y) (and therefore higher 1H24 margin income of IDR12.6tn [12% y-y}), and 2) stabilizing funding costs of ~2.2-2.6% in the past 12 months (which enabled it to have one of the lowest funding costs among the Indonesia banks under our coverage). We attribute BRIS’ low funding costs to the bank’s dominant position in the sharia banking. It is also the main transactional bank in the sharia banking space.

• Meanwhile, 2Q24 PPOP rose to IDR2.8tn (flat q-q; +3% y-y), bringing 1H24 PPOP to IDR5.6tn (+4% y-y) accounting for 46% of our FY24F projections. Combined with the lower 2Q24 provision expense of 1.0% (vs 1.8% in 2Q23), the bank’s 2Q24 net profit reached IDR1.7tn (-1% q-q; +24% y-y), bringing 1H24 profits to IDR3.4tn (+20% y-y) accounting for 54% of our FY24F projections. Thus, we think BRIS is on track to meet if not exceed our FY24F projections. Overall, the implied ROAA in 2Q24 stood at a strong 1.9% (+14bp y-y), with ROAE of 16.4% (+103bp y-y).

• On the balance sheet, BRIS booked financing growth of 16% y-y, higher than the sector growth. On funding, the bank reported financing (deposits) growth of 31% y-y. This implies LFR of 73.3% (-473p q-q: -968bp y-y), still relatively considerable compared to the broader banking sector in Indonesia.

Valuation and Risks

Our TP of IDR3,100 is based on DuPont methodology, with key parameters as follows: a risk-free rate of 6.5%, an equity risk premium of 7.8%, beta of 1.2x and a CAR-adjusted ROAE of 17.9%. Our TP implies a FY24F P/B of 2.8x (from a current valuation of 2.7x) and a FY24F P/E of 20.3x (19.9x at the current price). Risks are worsening macroeconomic trends, unfavorable regulatory changes, tighter liquidity competition that could increase funding costs, worsening credit quality that could raise credit costs, material management changes, and/or persistently high opex.

Fig. 1: BRIS Q-Q summary

 BRIS Q-Q SUMMARY            
  (IDR bn) 2Q234Q231Q242Q24Q-Q %Y-Y %YTD24YTD23Y-Y %FY24F%
 Margin inc 5,7005,9876,3086,3360%11%12,64411,31912%24,92851%
 Margin exp 1,4541,6961,9271,9340%33%3,8612,77839%6,41560%
 Net margin inc 4,2464,2914,3814,4020%4%8,7838,5413%18,51347%
 Non-int inc 7438949871,0011%35%1,9881,51331%  4,20447%
 Total op inc 4,9905,1855,3685,4031%8%10,77110,0537%22,71847%
 Non-margin exp 2,2642,8052,5532,5831%14%5,1364,62711%10,49749%
 PPOP 2,7262,3802,8152,8200%3%5,6355,4274%12,22146%
 Provisions 9273725495846%-37%1,1331,689-33%3,83730%
 NP 1,3641,5041,7071,687-1%24%3,3952,82220%6,30154%
         
 Gross financing/loans 209,503226,184231,980242,1824%16%7.1%7%
 Funding 252,516293,776297,339330,46011%31%46.1%-3%
Source: Company data, Verdhana research

 

Fig. 2: BRIS ratio

 BRIS Ratios (%) 2Q234Q231Q242Q24
 NFM %                5.9               5.5               5.3               5.3
 LFR %              83.0             77.0             78.0             73.3
 Loan YTD %                6.9             15.4               2.6               7.1
 Loan y-y %              17.9             15.4             15.1             15.6
 Loan q-q %                4.0               3.6               2.6               4.4
 Deposit YTD %               (3.4)             12.3               1.2             12.5
 Deposit y-y %                3.2             12.3             10.4             30.9
 Deposit q-q %               (6.2)             12.1               1.2             11.1
 CIR %              45.4             54.1             47.6             47.8
 CAR %              20.3             21.0             21.3             21.3
 NPL %                2.4               2.2               2.1               2.1
 NPL cov %            190.9           197.4           200.1           197.1
 LAR %              11.1               9.1               8.6               8.4
 LAR cov %              39.9             44.9             46.7             46.9
 ROAE %              15.4             15.8             17.2             16.4
 ROAA %                1.7               1.8               1.9               1.9
 LLR %                4.7               4.4               4.3               4.2
 Asset to equity x                8.7               9.1               8.8               8.7
 Credit cost %                1.8               0.7               1.0               1.0
 BVPS IDR               778              840              879              903
Source: Company data, Verdhana research

 

INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general. 

GENERAL DISCLOSURE/DISCLAIMER 
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).

This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.

The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.


This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.

ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views.  The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.


RESTRICTIONS ON DISTRIBUTION

By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations. 

Rating
Remains
Buy
Target price
Remains
IDR 3,100
Closing price
2 September 2024
IDR 2,610

Indonesia Research Team


Nicholas Santoso 
(nicholas.santoso@verdhana.id)

Erwin Wijaya (erwin.wijaya@verdhana.id)